WHO ICTRP trial

Sydney Epilepsy Incidence Study To Measure Illness Consequences

ACTRN12609000059268 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting

Key facts

Trial ID ACTRN12609000059268
Public title Sydney Epilepsy Incidence Study To Measure Illness Consequences
Scientific title Sydney Epilepsy Incidence Study To Measure Illness Consequences (SEISMIC) - A cohort study of people newly diagnosed with epilepsy and the associated psychosocial, educational and economic sequelae
Primary sponsor The George Institute for International Health
Secondary sponsors Epilepsy Action, Australia
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Not Recruiting
Study type Observational
Phase Not Applicable
Countries Australia
Conditions Epilepsy; Epilepsy;Neurological - Epilepsy
Interventions Epilepsy is one of the most common serious brain disorders in Australia. The fundamental characteristic of epilepsy is recurrent unprovoked seizures; a clinical manifestation presumed to result from an abnormal and excessive discharge of a…
Registration date Jan 23, 2009
Target size 506
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations